Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 2, 2005
J Am Soc Nephrol 16: 997-1004, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004050367

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004050367v1
16/4/997    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uchimura, H.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uchimura, H.
Right arrow Articles by Fujita, T.

Basic Immunology and Pathology

Intrarenal Injection of Bone Marrow-Derived Angiogenic Cells Reduces Endothelial Injury and Mesangial Cell Activation in Experimental Glomerulonephritis

Hideki Uchimura*, Takeshi Marumo{dagger},{ddagger}, Osamu Takase*, Hiroshi Kawachi§, Fujio Shimizu§, Matsuhiko Hayashi*, Takao Saruta*, Keiichi Hishikawa{dagger},{ddagger} and Toshiro Fujita{dagger},{ddagger}

* Department of Internal Medicine, Keio University School of Medicine, Tokyo; {dagger} Department of Clinical Renal Regeneration and {ddagger} Division of Nephrology and Endocrinology, Department of Internal Medicine, University of Tokyo, Tokyo; and § Department of Cell Biology, Institute of Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

Address correspondence to: Dr. Takeshi Marumo, Department of Clinical Renal Regeneration, Division of Nephrology and Endocrinology, Department of Internal Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyouku, 113-8655 Tokyo, Japan. Phone: 81-3-3815-5411, ext. 35717; Fax: 81-3-5800-9738; E-mail: tmarumo-npr{at}umin.ac.jp

Received for publication May 10, 2004. Accepted for publication January 1, 2005.

Loss of glomerular endothelial cells has been suggested to contribute to the progression of glomerular injury. Although therapeutic angiogenesis induced by administration of bone marrow–derived endothelial progenitor cells has been observed in disease models of endothelial injury, the effects on renal disease have not been clarified. Whether administration of culture-modified bone marrow mononuclear cells would mitigate the glomerular endothelial injury in anti-Thy1.1 nephritis was investigated. After cultivation under conditions that promote endothelial progenitor cell growth, bone marrow mononuclear cells were labeled with CM-DiI, a fluorescence marker, and injected into the left renal artery of Lewis rats with anti-Thy1.1 glomerulonephritis. The decrease in glomerular endothelial cells was significantly attenuated in the left kidney, as compared with the right, in nephritic rats that received the cell infusion. Glomerular injury score, the area positive for mesangial {alpha}-smooth muscle actin, and infiltration of macrophages were significantly decreased in the left kidney. CM-DiI–positive cells were distributed in glomeruli of the left kidney but not in those of the right kidney. Among CM-DiI–labeled cells incorporated into glomeruli, 16.5 ± 1.2% of cells were stained with an endothelial marker, rat endothelial cell antigen-1. Culture-modified mononuclear cells secreted 281.2 ± 85.0 pg of vascular endothelial growth factor per 105 cells per day. In conclusion, intra-arterial administration of culture-modified bone marrow mononuclear cells reduced endothelial injury and mesangial activation in anti-Thy1.1 glomerulonephritis. Incorporation into the glomerular endothelial lining and production of angiogenic factor(s) are likely to contribute to the protective effects of culture-modified mononuclear cells against glomerular injury.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
V. W. S. Lee, Y. M. Wang, Y. P. Wang, D. Zheng, T. Polhill, Q. Cao, H. Wu, I. E. Alexander, S. I. Alexander, and D. C. H. Harris
Regulatory immune cells in kidney disease
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F335 - F342.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Surdacki, E. Marewicz, E. Wieteska, G. Szastak, T. Rakowski, E. Wieczorek-Surdacka, D. Dudek, J. Pryjma, and J. S. Dubiel
Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2265 - 2273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Wang, Y. Wang, Q. Cai, G. Zheng, V. W.S. Lee, D. Zheng, X. Li, T. K. Tan, and D. C.H. Harris
By Homing to the Kidney, Activated Macrophages Potently Exacerbate Renal Injury
Am. J. Pathol., June 1, 2008; 172(6): 1491 - 1499.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Tongers and D. W. Losordo
Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2843 - 2852.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
N. Imai, K. Hishikawa, T. Marumo, J. Hirahashi, T. Inowa, Y. Matsuzaki, H. Okano, T. Kitamura, D. Salant, and T. Fujita
Inhibition of Histone Deacetylase Activates Side Population Cells in Kidney and Partially Reverses Chronic Renal Injury
Stem Cells, October 1, 2007; 25(10): 2469 - 2475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Rookmaaker, M. C. Verhaar, H. C. de Boer, R. Goldschmeding, J. A. Joles, H. A. Koomans, H.-J. Grone, and T. J. Rabelink
Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F624 - F630.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
U. Kunter, S. Rong, P. Boor, F. Eitner, G. Muller-Newen, Z. Djuric, C. R. van Roeyen, A. Konieczny, T. Ostendorf, L. Villa, et al.
Mesenchymal Stem Cells Prevent Progressive Experimental Renal Failure but Maldifferentiate into Glomerular Adipocytes
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1754 - 1764.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Rampino, G. Soccio, M. Gregorini, C. Guidetti, M. Marasa, M. Maggio, V. Panichi, M. Migliori, C. Libetta, and A. Dal Canton
Neutralization of Macrophage-Stimulating Protein Ameliorates Renal Injury in Anti-Thy 1 Glomerulonephritis
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1486 - 1496.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Neria, C. Caramelo, H. Peinado, F. R. Gonzalez-Pacheco, J. JP. Deudero, A. J. de Solis, R. Fernandez-Sanchez, S. Penate, A. Cano, and M{a} A. Castilla
Mechanisms of endothelial cell protection by blockade of the JAK2 pathway
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1123 - C1131.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Floege, U. Kunter, M. Weber, and O. Gross
Bone marrow transplantation rescues Alport mice
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2721 - 2723.
[Full Text] [PDF]


Home page
HypertensionHome page
T. Marumo, H. Uchimura, M. Hayashi, K. Hishikawa, and T. Fujita
Aldosterone Impairs Bone Marrow-Derived Progenitor Cell Formation
Hypertension, September 1, 2006; 48(3): 490 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
U. Kunter, S. Rong, Z. Djuric, P. Boor, G. Muller-Newen, D. Yu, and J. Floege
Transplanted Mesenchymal Stem Cells Accelerate Glomerular Healing in Experimental Glomerulonephritis
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2202 - 2212.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. J. Rabelink and C. van Kooten
Stem Cell Therapy for Glomerular Disease
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2086 - 2088.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. E.J. Reinders, T. J. Rabelink, and D. M. Briscoe
Angiogenesis and Endothelial Cell Repair in Renal Disease and Allograft Rejection
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 932 - 942.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP